Abstract
Phase I dose-escalation study for intravesical instillation of antisense oligonucleotide FFC15-01 against Ki-67 in patients with non muscle invasive bladder cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have